Skip to main content

INFLUENCIA DE LA DIETA Y LA MICROBIOTA INTESTINAL EN LA RESOLUCION DE LA ALERGIA A PROTEINAS DE LA LECHE DE VACA EN LA INFANCIA

PID2019-104546RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Critical features of an in vitro intestinal absorption model to study the first key aspects underlying food allergen sensitization

  • Dijk, Wieneke
  • Villa, Caterina
  • Benedé, Sara
  • Vassilopoulou, Emilia
  • Mafra, Isabel
  • Garrido-Arandia, María
  • Martínez-Blanco, Mónica
  • Bouchaud, Grégory
  • Hoppenbrouwers, Tamara
  • Bavaro, Simona L.
  • Giblin, Linda
  • Knipping, Karen
  • Castro Reigía, Ana María
  • Delgado, Susana
  • Costa, Joana
  • Bastiaan-Net, Shanna
New types of protein sources will enter our diet in a near future, reinforcing the need for a straightforward in vitro (cell-based) screening model to test and predict the safety of these novel proteins, in particular their potential risk for de novo allergic sensitization. The Adverse Outcome Pathway (AOP) for allergen sensitization describes the current knowledge of key events underlying the complex cellular interactions that proceed allergic food sensitization. Currently, there is no consensus on the in vitro model to study the intestinal translocation of proteins as well as the epithelial activation, which comprise the first molecular initiation events (ME1-3) and the first key event of the AOP, respectively. As members of INFOGEST, we have highlighted several critical features that should be considered for any proposed in vitro model to study epithelial protein transport in the context of allergic sensitization. In addition, we defined which intestinal cell types are indispensable in a consensus model of the first steps of the AOP, and which cell types are optional or desired when there is the possibility to create a more complex cell model. A model of these first key aspects of the AOP can be used to study the gut epithelial translocation behavior of known hypo- and hyperallergens, juxtaposed to the transport behavior of novel proteins as a first screen for risk management of dietary proteins. Indeed, this disquisition forms a basis for the development of a future consensus model of the allergic sensitization cascade, comprising also the other key events (KE2-5)., Fundação para a Ciência e Tecnologia,Grant/Award Numbers: PTDC/BAA-AGR/31720/2017, PTDC/BAA-AGR/4005/2021, UIDB/50006/2020|UIDP/50006/2020,2021.03670.CEECIND,2021.03583.CEECIND; Fondation pour la Recherche Médicale; Ministerio de Economía, Industria y Competitividad of the Government of Spain, Grant/Award Number: AGL2017-88964-R; The Spanish Ministry of Science and Innovation, Grant/Award Number: PID2019-104546RB-I00/AEI/10.13039/; Pays de La Loire region, Grant/AwardNumber: FEDER funds through COMPETE POCI-01-0145-FEDER-29871; European Union, Grant/Award Number: NORTE-01-0145-FEDER-000052; Dutch Ministry of Agriculture, Nature and Food Quality, Grant/Award Numbers:KB-37-001-007, TKI-PPSLWV20.123;INRAE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Arabinoxylan-based substrate preferences and predicted metabolic properties of Bifidobacterium longum subspecies as a basis to design differential media

  • Calvete-Torre, Inés
  • Sabater, Carlos
  • Delgado, Susana
  • Ruas-Madiedo, Patricia
  • Rupérez-García, Alicia
  • Montilla, Antonia
  • Moreno, F. Javier
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
Arabinoxylan (AX) and arabinoxylo-oligosaccharides (AXOS) derived therefrom are emergent prebiotics with promising health promoting properties, likely linked to its capacity to foster beneficial species in the human gut. Bifidobacteria appear to be one taxa that is frequently promoted following AX or AXOS consumption, and that is known to establish metabolic cross-feeding networks with other beneficial commensal species. Therefore, probiotic bifidobacteria with the capability to metabolize AX-derived prebiotics represent interesting candidates to develop novel probiotic and synbiotic combinations with AX-based prebiotics. In this work we have deepen into the metabolic capabilities of bifidobacteria related to AX and AXOS metabolization through a combination of in silico an in vitro tools. Both approaches revealed that Bifidobacterium longum and, particularly, B. longum subsp. longum, appears as the better equipped to metabolize complex AX substrates, although other related subspecies such as B. longum subsp. infantis, also hold some machinery related to AXOS metabolization. This correlates to the growth profiles exhibited by representative strains of both subspecies in AX or AXOS enriched media. Based on these results, we formulated a differential carbohydrate free medium (CFM) supplemented with a combination of AX and AXOS that enabled to recover a wide diversity of Bifidobacterium species from complex fecal samples, while allowing easy discrimination of AX metabolising strains by the appearance of a precipitation halo. This new media represent an appealing alternative to isolate novel probiotic bifidobacteria, rapidly discriminating their capacity to metabolize structurally complex AX-derived prebiotics. This can be convenient to assist formulation of novel functional foods and supplements, including bifidobacterial species with capacity to metabolize AX-derived prebiotic ingredients., The work in our research groups was funded by the grants from the Spanish State Research Agency RTI2018-095021-J-I00, AGL2016-78311-R and AGL 2017-84614-C2-1-R (funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”), PID2019-104546RB-100 (funded by MCIN/ AEI /10.13039/501100011033), and TED2021-131541B-100 funded by MCIN/AEI/10.13039/501100011033 and Europe Union "NextGenerationEU"/PRTR. We also thank the grant AYUD-2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER), CSIC for funding this research with the grant PIE-201970E019, and grant 101060130, funded by HORIZON-WIDERA-2021-ACCESS-02. CS is a postdoctoral researcher supported by the Juan de la Cierva-Formación Postdoctoral Trainee Program from MICINN, the Spanish Ministry of Science and Innovation (FJC2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gut microbiota and inflammatory mediators differentiate IgE mediated and non-IgE mediated cases of cow's milk protein at diagnosis

  • Castro Reigía, Ana María
  • Gutiérrez-Díaz, Isabel
  • Saiz, María L.
  • Navarro, Sandra
  • Suárez, Marta
  • Carbajal, Ignacio
  • García, Águeda
  • Sariego, Lydia
  • Toyos, Paula
  • Rodríguez, Silvia
  • Jiménez, Santiago
  • González, David
  • Molinos, Cristina
  • Pérez-Solis, David
  • Fernández, Porfirio
  • Suárez-Álvarez, Beatriz
  • Margolles Barros, Abelardo
  • Díaz, Juan J
  • Delgado, Susana
Objective Analyze fecal and blood samples at point of diagnosis in IgE mediated cow's milk protein allergy (CMPA) and non-IgE mediated (NIM)-CMPA patients to look for potential new biomarkers. Patients and Methods Fourteen patients with IgE mediated CMPA and 13 with NIM-CMPA were recruited in three hospitals in the north of Spain, and were compared with 25 infants from a control group of the same age range. To characterize intestinal microbiota, 16S rDNA gene and internal transcribed spacer amplicons of bifidobacteria were sequenced with Illumina technology. Fatty acids were analyzed by gas chromatography, meanwhile intestinal inflammation markers were quantified by enzyme-linked immunosorbent assay and a multiplex system. Immunological analysis of blood was performed by flow cytometry. Results The fecal results obtained in the NIM-CMPA group stand out. Among them, a significant reduction in the abundance of Bifidobacteriaceae and Bifidobacterium sequences with respect to controls was observed. Bifidobacterial species were also different, highlighting the lower abundance of Bifidobacterium breve sequences. Fecal calprotectin levels were found to be significantly elevated in relation to IgE mediated patients. Also, a higher excretion of IL-10 and a lower excretion of IL-1ra and platelet derived growth factor-BB was found in NIM-CMPA patients. Conclusions The differential fecal parameters found in NIM-CMPA patients could be useful in the diagnosis of NIM food allergy to CM proteins., This work was supported by Spanish Ministry of Science and Innovation reference: PID2019-104546RB-I00/AEI/10.13039 and Principality of Asturias Government (FICYT, supported by FEDER) Grant AYUD/2021/50910. I. G-D. has a grant FJC2021-047052-I financed by MCIN/AEI/10.13039/501100011033 and by European Union “NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Evolutive Study of Dietary Aspects and Intestinal Microbiota of Pediatric Cohort with Cow's Milk Protein Allergy

  • Castro, Ana M.
  • Navarro, Sandra
  • Carvajal, Ignacio
  • García, Agueda
  • Suárez, Marta
  • Toyos, Paula
  • Rodríguez, Silvia
  • Jimenez, Santiago
  • González, David
  • Molinos, Cristina
  • Pérez-Solís, David
  • Fernández, Porifirio
  • Margolles Barros, Abelardo
  • Díaz-Martín, Juan José
  • Gutiérrez-Díaz, Isabel
  • Delgado, Susana
One of the most common food allergies in the pediatric population is allergy to cow's milk protein (CMPA). Treatment consists of avoiding cow's milk proteins in lactating mothers and/or using therapeutic formulas based on hydrolysates or vegetable formulas. In infants with CMPA at diagnosis, a different gut microbial profile has been found compared to healthy children, with a reduction in beneficial bacteria. The aim of this study was to evaluate changes in the gut microbiota profile and its metabolites, dietary patterns and anthropometric variables in a pediatric cohort with CMPA after six months on a restrictive diet compared to healthy controls., This research was funded by the Spanish Ministry of Science and Innovation, Grant/Award Number: PID2019-104546RBI00/AEI/10.13039; and the Principality of Asturias Government, Grant/Award Number: Grant AYUD/2021/50910. I.G.-D. was awarded with MCIN/AEI/10.13039/501100011033, grant number: FJC2021-047052-I, support from European Union Next Generation EU/PRTR, and A.M.C. was awarded with a fellowship from ISPA with support from Fundació Banc Sabadell., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The intestinal microbiome of infants with cow's milk-induced FPIES is enriched in taxa and genes of enterobacteria

  • Castro Reigía, Ana María
  • Sabater, Carlos
  • Gutiérrez-Díaz, Isabel
  • Navarro, Sandra
  • Rodriguez, Silvia
  • Molinos, Cristina
  • Jiménez, Santiago
  • Claver, Angela
  • Espin, Beatriz
  • Domínguez, Gloria
  • Coronel, Cristóbal
  • Toyos, Paula
  • Sariego, Lydia
  • Fernández, Porfirio
  • Perez, David
  • Margolles Barros, Abelardo
  • Díaz-Martín, Juan José
  • Delgado, Susana
Sequencing files and metadata were deposited inthe Sequence Read Archive of the National Centerfor Biotechnology Information under bioprojectscodes PRJNA1036152 for amplicons sequences andPRJNA1037775 for shotgun sequences, Food protein-induced enterocolitis syndrome (FPIES) is a severe type of non-IgE (immunoglobulin E)-mediated (NIM) food allergy, with cow's milk (CM) being the most common offending food. The relationship between the gut microbiota and its metabolites with the inflammatory process in infants with CM FPIES is unknown, although evidence suggests a microbial dysbiosis in NIM patients. This study was performed to contribute to the knowledge of the interaction between the gut microbiota and its derived metabolites with the local immune system in feces of infants with CM FPIES at diagnosis., IsabelGutiérrez‐Díaz has a grant FJC2021‐047052‐I financed byMCIN/AEI/10.13039/501100011033. Ana M. Castro ac-knowledges her predoctoral research contract funded bythe Instituto de Investigación Sanitaria del Principado deAsturias and Fundació Banc Sabadell. The work waspartially supported by The Spanish Ministry of Science andInnovation through the project MICROALERGYMILK(PID2019‐104546RB‐I00/AEI/10.13039/) and FJC2019‐042125‐I. Susana Delgado is part of the CSIC's GlobalHealth Platform (PTI Salud Global), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Estudio de enriquecimientos funcionales en el proteoma y transcriptoma humano fecal en FPIES a la proteína de leche de vaca

  • Castro, Ana María
  • Méndez, Lucía
  • Margolles Barros, Abelardo
  • Medina, Isabel
  • Delgado, Susana
Poster.-- 18ª Reunión de la Red Española de bacterias Lácticas, Bacterias lácticas en alimentos y microbiota intestinal: aplicaciones biotecnológicas y en la salud, Oviedo, 5 y 6 de junio de 2025, El síndrome de enterocolitis inducido por proteínas alimentarias (FPIES) es un cuadro grave de alergia no mediada por inmunoglobulina E, con sintomatología fundamentalmente digestiva y caracterizado por presentar un diagnóstico complicado. El objetivo de este estudio, fue identificar las proteínas de origen humano así como los genes relacionados con la respuesta inflamatoria, presentes en las heces de niños lactantes diagnosticados con FPIES, con el fin de detectar, mediante análisis de enriquecimiento funcional, los potenciales procesos biológicos y rutas metabólicas activadas en dichos pacientes FPIES, y que a nivel local puedan ser relevantes en el diagnóstico del síndrome, Este trabajo fue realizado dentro de los proyectos PID2023-146221OB-I00 y PID2019-104546RB-100 financiado por MCIN/ AEI, y el proyecto IN607B 2023/05, financiado por la Agencia Gallega de Innovación (GAIN). Castro AM, disfruta de un Contrato de Investigación predoctoral ISPA 2023 (ITM-PRE-DOC-23-11) con el soporte de la Fundació Banc Sabadell, Peer reviewed